The Creation of Psychopharmacology and over one million other books are available for Amazon Kindle. Learn more

Have one to sell? Sell yours here
The Creation of Psychopharmacology
 
 
Start reading The Creation of Psychopharmacology on your Kindle in under a minute.

Don't have a Kindle? Get your Kindle here, or download a FREE Kindle Reading App.

The Creation of Psychopharmacology [Hardcover]

David Healy (Author)
3.2 out of 5 stars  See all reviews (4 customer reviews)


Available from these sellers.


Textbook Student FREE Two-Day Shipping for Students. Learn more

Formats

Amazon Price New from Used from
Kindle Edition $13.75  
Hardcover --  
Paperback $25.44  

Book Description

0674006194 978-0674006195 March 30, 2002 1

David Healy follows his widely praised study, The Antidepressant Era, with an even more ambitious and dramatic story: the discovery and development of antipsychotic medication. Healy argues that the discovery of chlorpromazine (more generally known as Thorazine) is as significant in the history of medicine as the discovery of penicillin, reminding readers of the worldwide prevalence of insanity within living memory.

But Healy tells not of the triumph of science but of a stream of fruitful accidents, of technological discovery leading neuroscientific research, of fierce professional competition and the backlash of the antipsychiatry movement of the 1960s. A chemical treatment was developed for one purpose, and as long as some theoretical rationale could be found, doctors administered it to the insane patients in their care to see if it would help. Sometimes it did, dramatically. Why these treatments worked, Healy argues provocatively, was, and often still is, a mystery. Nonetheless, such discoveries made and unmade academic reputations and inspired intense politicking for the Nobel Prize.

Once pharmaceutical companies recognized the commercial potential of antipsychotic medications, financial as well as clinical pressures drove the development of ever more aggressively marketed medications. With verve and immense learning, Healy tells a story with surprising implications in a book that will become the leading scholarly work on its compelling subject.

(20020507)


Editorial Reviews

From Library Journal

The standard historical view of psychiatry claims that the invention of chlorpromazine (a.k.a. Thorazine) in 1952 ushered in biologically based "scientific" psychiatry. Healy (The Antidepressant Era) claims that earlier psychiatry was also scientifically based and had some notable successes, such as the treatment of catatonia with shock therapy. Healy's second theme is that because the success of psychiatric drugs, the choice of treatment options is largely dependent on the financial preferences of the pharmaceutical industry. For example, the author argues that "randomized controlled trials" of drugs are favored by the pharmaceutical industry because they allow products to be marketed to a wide audience, but what is desperately needed is more research on the effects of medications on more specific types of patients. While this theme has certainly been sounded before (T.R. Luhrmann's Of Two Minds is an accessible discussion of the pitfalls of drug-based psychiatry), the detailed history of the development of psychiatric drugs and the "culture" surrounding them makes this book unique. For academic libraries. Mary Ann Hughes, Neill P.L., Pullman, WA
Copyright 2002 Cahners Business Information, Inc.

Review

[T]his sweeping history of medicine used to treat mental illness takes on the psychiatric and medical establishment...Healy does groundbreaking work...The Creation of Psychopharmacology details how psychiatric medication intersects with academic squabbles and popular culture. (Janice Paskey Chronicle of Higher Education 20030201)

David Healy is a respected historian of psychiatry who has written a book that should spark a major debate. He identifies current trends towards the abandonment of independent research into treatments for mental illness, the demand for Randomised Control Trials as the only acceptable measure of whether a treatment works, and the chilling control pharmaceutical companies now exert over psychiatry...This is an important and thought-provoking book...Healy's warning that, without a debate, we may be moving into an era when cosmetic psychiatry will be the new liposuction is worth heeding. (Julie Wheelwright The Independent 20040401)

This book is a good place to start if you want to get an overview of the role of drugs in the treatment of mental illness...[Healy] capture[s] an important current dilemma. (Richard Restak Washington Times )

Psychiatrists and historians owe a debt to David Healy. Over the years he has conducted interviews with all the leading figures in psychopharmacology...Drawing on these interviews and his wide reading of the scholarly literature, Healy has now constructed a subtle and compelling narrative of the development of psychotropic drugs...Healy ambitiously relates the emergence of drugs to the wider culture and shows how the two have interacted...[He] has written a highly stimulating and original book, which is brimful of ideas and deserves to be read and debated throughout the psychiatric community and beyond. (Allan Beveridge British Journal of Psychiatry )

[N]o one has described it more thoroughly, or elucidated the critical intersections between psychiatry and the pharmaceutical industry more clearly. (Morgan T. Sammons Contemporary Psychology )

Product Details

  • Hardcover: 480 pages
  • Publisher: Harvard University Press; 1 edition (March 30, 2002)
  • Language: English
  • ISBN-10: 0674006194
  • ISBN-13: 978-0674006195
  • Product Dimensions: 9.3 x 6.3 x 1.4 inches
  • Shipping Weight: 1.7 pounds
  • Average Customer Review: 3.2 out of 5 stars  See all reviews (4 customer reviews)
  • Amazon Best Sellers Rank: #2,606,032 in Books (See Top 100 in Books)

More About the Author

Discover books, learn about writers, read author blogs, and more.

 

Customer Reviews

4 Reviews
5 star:    (0)
4 star:
 (3)
3 star:    (0)
2 star:    (0)
1 star:
 (1)
 
 
 
 
 
Average Customer Review
3.2 out of 5 stars (4 customer reviews)
 
 
 
 
Share your thoughts with other customers:
Most Helpful Customer Reviews

22 of 25 people found the following review helpful:
4.0 out of 5 stars most objective, nuanced history of psychopharmaceuticals, December 21, 2002
By 
This review is from: The Creation of Psychopharmacology (Hardcover)
David Healy is probably the top historian of psychopharmacology in the last three years. He tells the story of the use of neuroleptics in treating schizophrenia that shows how the interests of certain parties (ie pharmaceutical companies and psychiatrists desperate to do something about horrendous and overcrowded conditions in state mental hospitcals) came to define the nature of psychopharmaceuticals and even the nature of schizophrenia - a pretty vaguely-defined illness - itself. Somehow, chlorpromazine went from being looked at as pretty similar as lobotomy, insulin therapy, or many of the other treatments previously used for schizophrenia, in the early 1950s, to being a magic bullet, saving schizophrenics from a lifetime of insanity without side effects, which is simply not the case.

As the previous reviewer notes, Healy seems to give short shrift to some evidence. However, Healy's coming from the perspective of a historian of science - a discipline that tends to begin with a critical analysis and without starting from the viewpoint that science is king, but the viewpoint of a skeptic. To use the example of the previous reviewer, Healy's point when e talks about the withdrawal symptoms of SSRI's is partially to note that, when we talk about mental illness and that fuzzy boundary between the mental and the physical, there's a lot of flexibility in where that boundary is placed in the mind of the public. The concept of withdrawal itself *is* a very fluid, unscientific one: why some classes of drugs are considered to exhibit withdrawal effects while others dont is a highly politicized question - one whose answer lies more on the side of special interests and the state of american politics than real scientific evidence.

one more note: the other major history of psychopharmacology to date is judith swazey's 1974 "chlorpromazine in psychiatry: a revolution in innovation." if you read swazey's book you can see why a critical history of psychopharmacology was desperately needed. this book balances the picture and serves as an excellent introduction to the history of psychopharmacology without being overly optimistic about medicine and progress.

Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No


3 of 3 people found the following review helpful:
4.0 out of 5 stars The Creation of Psychopharmacology -Healy, March 18, 2007
I'm embarrassed to say that I had not read this book until recently. I was aware that it existed and even had a copy laying around for over 3 years. Convergent events led me to read it and I must say that I found it particularly enjoyable. Readers will need to have more than a modicum of knowledge in several fields of science. Those that do will be rewarded with a book that is difficult to put down.

My only criticism: The editing is poor. Someone with a better knowledge of punctuation needed to have reviewed this before publication. There are also more than a few sentence fragments, misspellings, and poor word choices. In the context of his otherwise thoughtful and clearly highly educated prose, these editorial errors stuck out like a sore thumb.

Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No


1 of 1 people found the following review helpful:
4.0 out of 5 stars A critique of the antidepressant industry, July 10, 2011
You may remember David Healy's rise to headlines when a Canadian University fired him on his first day. He had committed the academic error of biting the hand that fed him by criticizing the pharmaceutical industry that funded his chair.
This book is a critique of that industry regarding psychotropic drugs, and in particular the role of marketing and government regulations in that industry. Fascinating to read, though the chemical details were often a bit above my head, was the description of how copy-cat drugs are developed, and why claims for specificity are laughable hoaxes. The choice for calling some of these drugs antipsychotics and others antidepressants he calls a matter of historical accident. In fact, he says, in Japan, depression is treated with atypical antipsychotics, not SSRIs.

Healy isn't coy about the horrific damage these drugs do, and the fact that doctors knew, or could have known, about it all along. It seems that doctors today are less, not more, aware of this harmfulness.

The book includes interesting historical notes, though I was occasionally dismayed by Healy's naive acceptance of unlikely case scenarios recorded by early psychiatrists. For instance, he uncritically quotes that people were cured by chlorpromazine after having been in catatonic states, "frozen into several positions" for years. How is it likely, in the days before medical heroics, that someone survived such a condition? Healy does not question it. What caused catatonia, how did chlorpromazine relieve it, and why is the condition unknown today? Healy does not say. Yet he acknowledges the fraud of psychiatric diagnoses in more recent times, as well as the deception in drug company testing.

Buried among the otherwise highly informative material is the odd statement that totally contradicts the rest of the book. For instance, Healy says about insulin coma therapy, "It... was used for twenty years... A therapy that did not produce some good would surely have faded away, given... the risk of fatalities." You would expect Healy to realize that medicine does not follow such logic, much less psychiatry. Furthermore, it did fade away, unlike the drugs which he criticizes. Equally baffling is his terse and unexplained claim for the efficacy of ECT. And though he himself coins the term "biobabble," he doesn't shirk from a bit of biobabble himself, such as "Brain imaging will make it clear that our brains are as social as they are biological and that being biological means having social arrangements stamped into our neuroendocrine systems."

Among the implied advice that Healy includes in his book is the abolition of regulations, yet he comments that they cannot be abolished. Why not? He also endorses the free availability of SSRIs, so without a doctor's prescription. But why not free availability of all drugs, as he himself states (though he is not the first to do so), "The `good' drugs are now difficult to access because they are available only by prescription, while the `bad' drugs, which prescription-only status was introduced to control, are widely available."

In short, Healy wrote an excellent book, though it contains the occasional slip which probably reflects a lack of critical editing.

Copyright © MeTZelf
Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No

Share your thoughts with other customers: Create your own review
 
 
 
Most Recent Customer Reviews


Only search this product's reviews



Inside This Book (learn more)
Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Surprise Me!
Search Inside This Book:



Suggested Tags from Similar Products

 (What's this?)
Be the first one to add a relevant tag (keyword that's strongly related to this product).
 
(3)

Your tags: Add your first tag
 

Customer Discussions

This product's forum
Discussion Replies Latest Post
No discussions yet

Ask questions, Share opinions, Gain insight
Start a new discussion
Topic:
First post:
Prompts for sign-in
 


Active discussions in related forums
Search Customer Discussions
Search all Amazon discussions
   
Related forums





Look for Similar Items by Category


Look for Similar Items by Subject